A multicenter trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic dermatitis in Korea

By Won CH   Seo PG   Park YM   Yang JM   Lee KH   Sung KJ   Park CW   Kim DW   Chang HS   Won YH   Kim KH  

Journal of Dermatological Treatment, Vol. 15, Iss. 1, 2004-01 ,pp. : 30-34

Informa Healthcare

Access to resources Recommend Favorite

Long-term Safety and Efficacy of Tacrolimus Ointment for the Treatment of Atopic Dermatitis in Children

By Remitz Anita   Harper John   Rustin Malcolm   Goldschmidt Wouter F. M.   Palatsi Riitta   van der Valk Pieter G. M.   Sharpe Graham   Smith Catherine H.   Dobozy Attila   Turjanmaa Kristiina    

Acta Dermato-Venereologica, Vol. 87, Iss. 1, 2007-01 ,pp. : 54-61

Medical Journals Limited

Access to resources Recommend Favorite

Long-term Treatment with 0.1% Tacrolimus Ointment in Adults with Atopic Dermatitis: Results of a Two-year, Multicentre, Non-comparative Study

By Reitamo Sakari   Ortonne Jean-Paul   Sand Carsten   Bos Jan   Cambazard Frédéric   Bieber Thomas   Grønhøj-Larsen Christian   Rustin Malcolm   Fölster-Holst Regina   Schuttelaar Marie  

Acta Dermato-Venereologica, Vol. 87, Iss. 5, 2007-09 ,pp. : 406-412

Medical Journals Limited

Access to resources Recommend Favorite

Safety and Efficacy of Tacrolimus Ointment Versus Pimecrolimus Cream in the Treatment of Patients with Atopic Dermatitis Previously Treated with Corticosteroids

By Kirsner Robert S.   Heffernan Michael P.   Antaya Richard  

Acta Dermato-Venereologica, Vol. 90, Iss. 1, 2010-01 ,pp. : 58-64

Medical Journals Limited

Access to resources Recommend Favorite

Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis

By Fleischer Alan B.   Abramovits William   Breneman Debra   Jaracz Eileen  

Journal of Dermatological Treatment, Vol. 18, Iss. 3, 2007-01 ,pp. : 151-157

Informa Healthcare

Access to resources Recommend Favorite